The Link Between Data Integrity and Quality Culture

This article examines the growing connection between an organization’s quality culture and the integrity of the data generated to support pharmaceutical product quality. Regulatory authorities have increasingly emphasized that reliable, accurate data depends not only on data integrity tools and procedures, but also on an organizational culture that encourages transparency, accountability, and the open reporting of failures and mistakes.

The article reviews the evolution of regulatory expectations surrounding data integrity, including FDA’s quality metrics initiative and guidance from organizations such as FDA, MHRA, WHO, and PIC/S. Common data integrity observations have included insufficient training, system failures, inadequate procedures, repeated human error, inappropriate system configuration, and intentional falsification. Across regulatory guidance, management leadership and organizational behavior are identified as important factors in maintaining complete, consistent, and accurate data.

Organizations can assess quality culture by examining both quality system attributes and the behaviors that support them. Areas such as deviation reporting, change control, CAPA, complaints, and environmental monitoring can be evaluated alongside transparency, communication, employee engagement, and cross-functional collaboration. By proactively assessing quality culture and addressing weaknesses, companies can better identify data integrity risks and support compliance with ALCOA principles before regulatory inspections.

Read the full article: Quality Culture and Data Integrity